PL365131A1 - Metoda skriningu - Google Patents

Metoda skriningu

Info

Publication number: PL365131A1
Authority: PL; Poland
Prior art keywords: sequences; polynucleotides; gene; proteins; peptides
Prior art date: 2000-08-03

Application number

PL01365131A

Other languages

English (en)

Inventor

Clemens Gillen

Ingrid Wetzels

Stephan Wnendt

Eberhard Weihe

Martin K.H. Schafer

Original Assignee

Grunenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2001-08-03

Publication date

2004-12-27

2001-08-03 Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh

2004-12-27 Publication of PL365131A1 publication Critical patent/PL365131A1/pl

Links

238000000034 method Methods 0.000 title abstract 4
238000012216 screening Methods 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 13
108091033319 polynucleotide Proteins 0.000 abstract 11
102000040430 polynucleotide Human genes 0.000 abstract 11
239000002157 polynucleotide Substances 0.000 abstract 11
108090000765 processed proteins & peptides Proteins 0.000 abstract 8
235000018102 proteins Nutrition 0.000 abstract 8
102000004169 proteins and genes Human genes 0.000 abstract 8
210000004027 cell Anatomy 0.000 abstract 5
102000004196 processed proteins & peptides Human genes 0.000 abstract 5
239000013598 vector Substances 0.000 abstract 4
239000012634 fragment Substances 0.000 abstract 3
239000000126 substance Substances 0.000 abstract 3
230000000202 analgesic effect Effects 0.000 abstract 2
230000000692 anti-sense effect Effects 0.000 abstract 2
239000002299 complementary DNA Substances 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
238000003752 polymerase chain reaction Methods 0.000 abstract 2
-1 CLC-7 Proteins 0.000 abstract 1
102000005403 Casein Kinases Human genes 0.000 abstract 1
108010031425 Casein Kinases Proteins 0.000 abstract 1
102000016938 Catalase Human genes 0.000 abstract 1
108010053835 Catalase Proteins 0.000 abstract 1
108020004414 DNA Proteins 0.000 abstract 1
102100028685 H(+)/Cl(-) exchange transporter 7 Human genes 0.000 abstract 1
101000628949 Homo sapiens Mitogen-activated protein kinase 10 Proteins 0.000 abstract 1
101001055092 Homo sapiens Mitogen-activated protein kinase kinase kinase 7 Proteins 0.000 abstract 1
101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 abstract 1
102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 abstract 1
102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 abstract 1
101100297651 Mus musculus Pim2 gene Proteins 0.000 abstract 1
108091000080 Phosphotransferase Proteins 0.000 abstract 1
102100040869 Tetraspanin-6 Human genes 0.000 abstract 1
101710151642 Tetraspanin-6 Proteins 0.000 abstract 1
102000043977 Tetraspanins Human genes 0.000 abstract 1
108700031126 Tetraspanins Proteins 0.000 abstract 1
102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 abstract 1
102000004887 Transforming Growth Factor beta Human genes 0.000 abstract 1
108090001012 Transforming Growth Factor beta Proteins 0.000 abstract 1
239000000654 additive Substances 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
238000001415 gene therapy Methods 0.000 abstract 1
210000004602 germ cell Anatomy 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
102000020233 phosphotransferase Human genes 0.000 abstract 1
210000001082 somatic cell Anatomy 0.000 abstract 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 1
230000009261 transgenic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Pathology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PL01365131A 2000-08-03 2001-08-03 Metoda skriningu PL365131A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10037759A DE10037759A1 (de)	2000-08-03	2000-08-03	Screeningverfahren
PCT/EP2001/009011 WO2002012338A2 (de)	2000-08-03	2001-08-03	Screeningverfahren

Publications (1)

Publication Number	Publication Date
PL365131A1 true PL365131A1 (pl)	2004-12-27

Family

ID=7651135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01365131A PL365131A1 (pl)	2000-08-03	2001-08-03	Metoda skriningu

Country Status (14)

Country	Link
US (1)	US20040087478A1 (pl)
EP (2)	EP1305636B1 (pl)
JP (1)	JP2004537962A (pl)
AT (2)	ATE319092T1 (pl)
AU (1)	AU2001282066A1 (pl)
CA (1)	CA2417972A1 (pl)
DE (3)	DE10037759A1 (pl)
DK (1)	DK1305636T3 (pl)
ES (2)	ES2260267T3 (pl)
HU (1)	HUP0301812A2 (pl)
MX (1)	MXPA03001015A (pl)
PL (1)	PL365131A1 (pl)
PT (1)	PT1305636E (pl)
WO (1)	WO2002012338A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE397090T1 (de) *	2001-05-23	2008-06-15	Boehringer Ingelheim Pharma	Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
EP1497797B1 (en)	2001-06-28	2010-08-04	Millennium Pharmaceuticals, Inc.	A human protein kinase family member and uses therefor
JP2005519947A (ja) *	2002-03-14	2005-07-07	デヴェロゲンアクチエンゲゼルシャフトフュアエントヴィックルングスビオローギッシェフォルシュング	エネルギー恒常性の調節に関与するｃｇ８３２７、ｃｇ１０８２３、ｃｇ１８４１８、ｃｇ１５８６２、ｃｇ１６７５０、ｃｇ３７６８およびｃｇ１１４４７相同タンパク質
DE10226702A1 (de) *	2002-06-14	2004-09-09	Grünenthal GmbH	Antisense Oligonukleotide gegen PIM1
WO2004070383A2 (de) *	2003-02-05	2004-08-19	Grünenthal GmbH	Identifizierung schmerzegulierter gene im drg nach cfa-arthritits
ES2307381B1 (es)	2006-04-12	2009-10-23	Bial Industrial Farmaceutica S.A.	Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
WO2010096496A2 (en)	2009-02-17	2010-08-26	Memorial Sloan-Kettering Cancer Center	Methods of neural conversion of human embryonic stem cells
TWI622402B (zh) *	2010-02-24	2018-05-01	免疫遺傳股份有限公司	葉酸受體１抗體類和免疫共軛物類及彼等之用途
DK3578988T3 (da)	2010-05-25	2025-02-24	Memorial Sloan Kettering Cancer Center	Fremgangsmåde til nociceptordifferentiering af humane embryonale stamceller og anvendelse heraf
BR112013025415B1 (pt)	2011-04-01	2021-03-16	Immunogen, Inc	uso de um imunoconjugado antirreceptor de folato 1 (folr1)
EP3693455A1 (en)	2011-11-04	2020-08-12	Memorial Sloan-Kettering Cancer Center	Midbrain dopamine (da) neurons for engraftment
WO2013113696A1 (en)	2012-01-30	2013-08-08	Vib Vzw	Means and method for diagnosis and treatment of alzheimer's disease
US9200073B2 (en)	2012-08-31	2015-12-01	Immunogen, Inc.	Diagnostic assays and kits for detection of folate receptor 1
EP3498824A1 (en)	2013-04-26	2019-06-19	Memorial Sloan-Kettering Cancer Center	Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
CN113150145B (zh)	2013-08-30	2025-02-14	伊缪诺金公司	用于检测叶酸受体1的抗体和测定
CN116440279B (zh)	2015-09-17	2026-02-24	伊缪诺金公司	包含抗folr1免疫缀合物的治疗组合
CA3058807A1 (en)	2017-04-03	2018-10-11	Biontech Us Inc.	Protein antigens and uses thereof
TW201930340A (zh)	2017-12-18	2019-08-01	美商尼恩醫療公司	新抗原及其用途
MX2020014243A (es)	2018-06-19	2021-05-12	Biontech Us Inc	Neoantigenos y usos de los mismos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2148898A1 (en) *	1994-05-09	1995-11-10	John M. Kyriakis	P54 stress-activated protein kinases
JPH09163988A (ja) *	1995-10-09	1997-06-24	Kowa Co	新規なｌｄｌ受容体類似蛋白質及び遺伝子
PT948604E (pt) *	1996-12-11	2004-10-29	Univ New York Medical Ct	Produtos e metodos relacionados com pyk2
DE69804446T3 (de) *	1997-04-07	2006-08-24	Bioimage A/S	Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen
CA2304108A1 (en) *	1997-09-09	1999-03-18	The Regents Of The University Of California	Inhibition of apoptotis using prosaposin receptor agonists
US6943000B2 (en) *	1997-10-03	2005-09-13	University Of Massachusetts	JNK3 modulators and methods of use
US6162613A (en) *	1998-02-18	2000-12-19	Vertex Pharmaceuticals, Inc.	Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
WO2000043524A1 (fr) *	1999-01-20	2000-07-27	Aventis Pharma S.A.	Polypeptides derives de jnk3
AU5316900A (en) *	1999-06-03	2000-12-28	Vertex Pharmaceuticals Incorporated	Inhibitors of c-jun n-terminal kinases (jnk)
TW200302722A (en) *	2002-02-13	2003-08-16	Astrazeneca Ab	Therapeutic agents
DE60316542T2 (de) *	2002-03-28	2008-07-03	Eisai R&D Management Co., Ltd.	7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen

2000
- 2000-08-03 DE DE10037759A patent/DE10037759A1/de not_active Withdrawn
2001
- 2001-08-03 PT PT01960621T patent/PT1305636E/pt unknown
- 2001-08-03 CA CA002417972A patent/CA2417972A1/en not_active Abandoned
- 2001-08-03 ES ES01960621T patent/ES2260267T3/es not_active Expired - Lifetime
- 2001-08-03 DE DE50111395T patent/DE50111395D1/de not_active Expired - Lifetime
- 2001-08-03 JP JP2002518309A patent/JP2004537962A/ja not_active Withdrawn
- 2001-08-03 WO PCT/EP2001/009011 patent/WO2002012338A2/de not_active Ceased
- 2001-08-03 DK DK01960621T patent/DK1305636T3/da active
- 2001-08-03 AT AT01960621T patent/ATE319092T1/de active
- 2001-08-03 AU AU2001282066A patent/AU2001282066A1/en not_active Abandoned
- 2001-08-03 US US10/343,710 patent/US20040087478A1/en not_active Abandoned
- 2001-08-03 MX MXPA03001015A patent/MXPA03001015A/es unknown
- 2001-08-03 EP EP01960621A patent/EP1305636B1/de not_active Expired - Lifetime
- 2001-08-03 PL PL01365131A patent/PL365131A1/pl unknown
- 2001-08-03 HU HU0301812A patent/HUP0301812A2/hu unknown
- 2001-08-03 DE DE50109087T patent/DE50109087D1/de not_active Expired - Lifetime
- 2001-08-03 AT AT04014603T patent/ATE344458T1/de active
- 2001-08-03 ES ES04014603T patent/ES2276192T3/es not_active Expired - Lifetime
- 2001-08-03 EP EP04014603A patent/EP1469316B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2260267T3 (es)	2006-11-01
EP1469316A8 (de)	2004-12-15
ES2276192T3 (es)	2007-06-16
EP1469316B1 (de)	2006-11-02
EP1469316A1 (de)	2004-10-20
AU2001282066A1 (en)	2002-02-18
PT1305636E (pt)	2006-07-31
MXPA03001015A (es)	2004-01-29
HUP0301812A2 (hu)	2003-09-29
EP1305636A2 (de)	2003-05-02
CA2417972A1 (en)	2003-01-31
WO2002012338A2 (de)	2002-02-14
DE50109087D1 (de)	2006-04-27
EP1469316A3 (de)	2005-01-05
DE10037759A1 (de)	2002-07-04
DK1305636T3 (da)	2006-07-10
ATE319092T1 (de)	2006-03-15
DE50111395D1 (de)	2006-12-14
WO2002012338A3 (de)	2002-12-19
US20040087478A1 (en)	2004-05-06
EP1305636B1 (de)	2006-03-01
ATE344458T1 (de)	2006-11-15
JP2004537962A (ja)	2004-12-24

Legal Events

Date	Code	Title	Description
2010-07-30	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
MXPA03001015A (es)	2004-01-29	Procedimiento de seleccion.
EP3321379B1 (en)	2020-09-16	Genetic marker for determining meat quality traits of pigs and use thereof
Nilsson et al.	2001	Cloning, characterization, and expression of human LIG1
AU2008201280B2 (en)	2010-06-03	Genes with ES cell-specific expression
Dinchuk et al.	2000	Aspartyl β-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin
TAKIYA et al.	1997	Transcriptional regulatory elements in the upstream and intron of the fibroin gene bind three specific factors POU-M1, Bm Fkh and FMBP-1
Latham et al.	1995	Stage-specific induction and regulation by genomic imprinting of the mouse U2afbp-rs gene during preimplantation development
JPH09502980A (ja)	1997-03-25	Ｎｆ−ａｔポリペプチド及びポリヌクレオチド
CA2679954A1 (en)	2008-09-12	Assessment of risk for colorectal cancer
Umeki et al.	2002	Two novel missense mutations in the thyroid peroxidase gene, R665W and G771R, result in a localization defect and cause congenital hypothyroidism
Kay et al.	1990	Potential for two isoforms of the A1 ribonucleoprotein in Xenopus laevis.
Mutai et al.	2000	PAL31, a novel nuclear protein, expressed in the developing brain
WO2000000607B1 (en)	2000-03-09	A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
CA2323091A1 (en)	1999-09-23	Nephrin gene and protein
JP2022091235A (ja)	2022-06-21	アユ類の性識別マーカー
CN110452970A (zh)	2019-11-15	一种基因融合的微流控检测设备及其使用方法
WO2004111272A2 (en)	2004-12-23	Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer
US20030175797A1 (en)	2003-09-18	Association of protein kinase C zeta polymorphisms with diabetes
EP1403368B1 (en)	2010-09-01	Testicular carnitine transporter and its gene
KR101821552B1 (ko)	2018-01-25	돼지의 유두수 예측용 ｓｎｐ 마커 및 이를 이용한 다산 개체 예측방법
US20020155473A1 (en)	2002-10-24	Methods for identifying G-protein coupled receptors associated with diseases
US7160697B2 (en)	2007-01-09	Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
CN100590196C (zh)	2010-02-17	以单分子作用的支链中性氨基酸转运蛋白
US7307145B2 (en)	2007-12-11	Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function
CA2452260A1 (en)	2003-02-06	Novel variants and exons of the glyt1 transporter